Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia

[1]  M. L. Le Beau,et al.  An FHIT tumor suppressor gene? , 1998, Genes, chromosomes & cancer.

[2]  F. Kaye,et al.  Protein expression and functional analysis of the FHIT gene in human tumor cells. , 1998, Journal of the National Cancer Institute.

[3]  L. Mao.  Tumor suppressor genes: does FHIT fit? , 1998, Journal of the National Cancer Institute.

[4]  David I. Smith,et al.  Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact , 1998, Oncogene.

[5]  C. Croce,et al.  Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. D. Barnes,et al.  Replacement of Fhit in cancer cells suppresses tumorigenicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Chang,et al.  Aberrant FHIT transcripts in acute myeloid leukaemia , 1997, British journal of haematology.

[8]  M. Fey,et al.  Comparative detection and quantitation of human CDK inhibitor mRNA expression of p15INK4B, p16INK4A, p16β, p18INK4C, p19INK4D, p21WAF1, p27KIP1 and p57KIP2 by RT‐PCR using a polycompetitive internal standard , 1997, British journal of haematology.

[9]  Stanley N Cohen,et al.  Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours , 1997, Oncogene.

[10]  C. Lima,et al.  Structure-based analysis of catalysis and substrate definition in the HIT protein family. , 1997, Science.

[11]  D. Beer,et al.  Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas , 1997, Oncogene.

[12]  J. Minna,et al.  Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines , 1997, Genes, chromosomes & cancer.

[13]  A. Feinberg,et al.  Aberrant splicing but not mutations of TSG101 in human breast cancer. , 1997, Cancer research.

[14]  S. Naylor,et al.  Normal FHIT transcripts in renal cell cancer‐ and lung cancer‐derived cell lines, including a cell line with a homozygous deletion in the FRA3B region , 1997, Genes, chromosomes & cancer.

[15]  F. Mitelman,et al.  Variable FHIT transcripts in non‐neoplastic tissues , 1997 .

[16]  M. Kurosumi,et al.  Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases. , 1997, Cancer research.

[17]  K. Miyagawa,et al.  Decreased or Altered Expression of the FHIT Gene in Human Leukemias , 1997, Stem cells.

[18]  B. Johansson,et al.  A breakpoint map of recurrent chromosomal rearrangements in human neoplasia , 1997, Nature Genetics.

[19]  C. Croce,et al.  Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. , 1997, Cancer research.

[20]  R. Lotan,et al.  Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. , 1996, Cancer research.

[21]  L. D. Barnes,et al.  Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase. , 1996, Biochemistry.

[22]  C. Croce,et al.  The FHIT gene at 3p14.2 is abnormal in breast carcinomas. , 1996, Cancer research.

[23]  R. Espinosa,et al.  Direct cloning of DNA sequences from the common fragile site region at chromosome band 3p14.2. , 1996, Genomics.

[24]  B. Dewald,et al.  Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin , 1996, The Journal of experimental medicine.

[25]  C. Croce,et al.  The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer , 1996, Cell.

[26]  C. Croce,et al.  The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.

[27]  Y. Sanchez,et al.  A tumor suppressor locus within 3p14-p12 mediates rapid cell death of renal cell carcinoma in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Naylor,et al.  Definition of a tumor suppressor locus within human chromosome 3p21-p22. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[29]  H. Brauch,et al.  Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma , 1988, Nature.

[30]  J. Minna,et al.  Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. , 1987, The New England journal of medicine.

[31]  J. Yunis,et al.  Constitutive fragile sites and cancer. , 1984, Science.

[32]  J. Rowley,et al.  Cancer biology: Heritable fragile sites in cancer , 1984, Nature.

[33]  J. Stephenson,et al.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.